“Salmon DNA” is an informal ingredient description, while Rejuran is a brand. They are not interchangeable names for one treatment. Rejuran includes PN-based medical products, and related skincare products may use different ingredients and routes of application. Always ask which exact formulation is being proposed. [1] [2]

What do PN and PDRN mean?

PN stands for polynucleotides, chains made from nucleotide building blocks. PDRN means polydeoxyribonucleotide, another term used for DNA-derived material. In aesthetic discussions, PN is often used for longer chains and PDRN for shorter fragments, but terminology and specifications vary. The acronym alone does not tell you the source, purity, concentration or clinical evidence. [3]

These ingredients are processed and purified; a treatment is not an injection of raw fish material. Nor does the phrase “DNA treatment” mean it changes your inherited DNA. Product identity and the evidence for a specific use matter more than a memorable nickname.

Why the Rejuran name needs a closer look

PharmaResearch describes Rejuran as a PN-based medical device. Its cosmetics are a separate product category. A serum used on intact skin should not be expected to reproduce the delivery or outcomes of a professional injection, and a topical cosmetic must never be injected. [1] [2]

Even within one brand, products can differ. Ask for the full name on the packaging, intended treatment area and local registration. Photographs of a familiar box online are not enough to establish what a clinic plans to use.

What can treatment realistically do?

Research explores PN products for skin quality and wrinkles, but study sizes, formulations and protocols vary. Evidence for one product or anatomical area should not be presented as proof for every “salmon DNA” treatment. It is more useful to ask what change is likely in your concern than whether the ingredient is generally described as regenerative. [3]

For example, a fine-line concern and a deep structural hollow need different assessments. A skin-quality treatment should not be sold as an automatic replacement for volume correction or medical treatment of pigmentation.

What about safety?

Injections may cause temporary bumps, swelling or bruising, and infection or allergic reactions are possible. Discuss fish allergy, previous reactions, medicines, pregnancy and breastfeeding before choosing a product. Eligibility should follow its actual instructions, not the assumption that a naturally derived ingredient is safe for everyone. [3]

Four labels that should not be confused

A treatment discussion becomes clearer when four different labels are separated: the ingredient family, the product brand, the individual formulation and the route of use. “Salmon DNA” loosely describes an origin. PN and PDRN describe related material categories. Rejuran identifies a brand family. An injectable medical product and a topical cosmetic are different preparations used in different ways. [1] [2] [3]

When asking about treatment, request all four pieces of information. A clinic should be able to tell you the full product name, what it contains, where it is intended to be used and whether it is being injected or applied to the skin. Without those details, a comparison of prices, sessions or expected results is incomplete. Two offers carrying the same fashionable phrase may not involve the same intervention at all.

Why molecular language does not establish a result

Descriptions such as repair, regeneration and cellular signalling can sound like evidence of a visible clinical benefit. They may instead refer to a proposed mechanism, a laboratory finding or a particular study setting. These are useful parts of research, but they do not automatically establish how much improvement a person will see in a specific facial concern. [3]

Ask which outcome was actually measured. A change in a laboratory marker is different from a patient noticing fewer wrinkles, and a short-term improvement is different from a durable result. The relevant question is not whether a biological process sounds promising; it is whether the named product has useful evidence for the treatment being proposed. This distinction helps you discuss emerging treatments without either dismissing them or accepting every claim.

PN and PDRN in practical terms

Both terms relate to nucleotide chains derived from DNA material, but their use in commercial and scientific writing is not perfectly uniform. Chain length, processing, concentration and formulation can differ. For that reason, a label containing the letters PN or PDRN should not be treated as a complete specification or a guarantee of interchangeability. [3]

You do not need a chemistry degree to ask a useful question. “Which exact product is this, and what evidence supports its use around my eyes?” is more productive than asking whether PN is always better than PDRN. The first question connects the material to an anatomical area and an outcome. The second asks for a universal ranking that the available evidence may not support.

Rejuran injectables and Rejuran cosmetics

PharmaResearch describes Rejuran as a PN-based medical product, while its cosmetic range includes products designed for application to the skin. Shared branding does not mean those products have the same delivery, concentration or intended effect. The manufacturer’s discussion of its cosmetics distinguishes that category from the professional injectable treatment. [1] [2]

A topical product may be part of an everyday skincare routine, but it should not be presented as if it reproduces an injection simply because the ingredient story is similar. Equally, an injectable should not be viewed as a routine cosmetic purchase. It involves suitability assessment, procedural risks and aftercare. Never inject a product intended for topical use or buy an injectable for home administration.

What the evidence can currently support

The cited systematic review found promising findings for aesthetic PN use but also limitations in the quality, size and consistency of the studies. Different products, treatment areas and protocols make broad comparisons difficult. A positive study is therefore a reason to examine the details, not a reason to promise the same outcome for every product using the same acronym. [3]

Ask how closely the research resembles your situation. Was the product the same? Was the area similar? Were results assessed with a comparison group or only before-and-after photographs? How long were participants followed? These questions do not require you to audit the study yourself. They help the clinician explain why the evidence is relevant and where the uncertainty remains.

Match the concern to the treatment category

A skin-quality concern may involve fine lines, texture or hydration-related appearance. A structural hollow involves a different anatomical problem. Persistent pigmentation may require a diagnosis and a treatment directed at its cause. Calling all three concerns “tired skin” can obscure the distinction and make almost any treatment sound suitable.

Ask the clinician to identify the main feature that could reasonably improve with the proposed product. If the concern is a deep hollow or a prominent bag beneath the eye, clarify why a skin-quality treatment is being considered and what it cannot change. A useful plan may involve another approach or no procedure. It should not depend on the assumption that an emerging ingredient can replace every established treatment category.

A product comparison checklist

Before comparing two PN or PDRN offers, record:

The complete product and formulation name.
Whether the preparation is a medical injectable or a topical cosmetic.
The proposed anatomical area and treatment goal.
The evidence relevant to that product and use.
The current local authorisation and patient information.
The estimated course, review points and total cost.
The expected recovery and route to care for a complication.

If one of these details is missing, ask for it before choosing. A large discount or a familiar brand name cannot fill an information gap. The checklist also makes it easier to compare recommendations fairly when clinics use different terminology for similar concerns.

What a consultation should cover

Explain your skin history, previous procedures, allergies and current medicines. Mention pregnancy or breastfeeding and any active infection, rash or irritation in the proposed area. Fish allergy should be discussed rather than dismissed on the basis that the material has been purified. The clinician should apply the contraindications and precautions of the actual formulation. [3]

Bring photographs that show the concern in ordinary lighting, but expect an examination to be necessary. A treatment decision should not be based only on a filtered image or a brief messaging exchange. Ask what would make the practitioner advise against treatment. Understanding the limit of suitability is part of understanding the treatment itself.

Sessions, recovery and realistic expectations

The number of appointments should follow the specific product and clinical plan. A schedule advertised by one provider should not automatically be transferred to another formulation. Ask when the clinician expects to review tolerability and when it becomes reasonable to judge benefit. Those may be different appointments.

Temporary injection bumps, bruising or swelling may occur, so plan around work and important events. Ask what appearance is expected for your protocol and which symptoms require review. If a concern is worsening, do not assume that an ingredient described as regenerative means the reaction is part of a beneficial process. The clinical response matters more than the marketing language. [3]

How to compare benefit without relying on a glow claim

“Glow” is subjective and can change with lighting, makeup, moisturiser or recent sun exposure. If the treatment goal is skin quality, agree on a more concrete assessment: the appearance of a particular fine-line area, a texture concern or a patient-reported symptom. Consistent photographs and a clear review date make the discussion more useful.

Avoid changing several treatments and skincare products at once without a plan. If many things change simultaneously, it becomes harder to identify what helped or caused irritation. A clinician may deliberately combine interventions, but should explain the rationale and how response will be assessed. A comparison should acknowledge other treatments rather than assigning every visible improvement to one ingredient.

What price comparisons leave out

A price per syringe or per visit does not describe the full course. Ask whether the quotation includes consultation, the exact formulation, follow-up and any expected maintenance. Clarify whether further treatment is optional or considered necessary for the proposed goal. This helps you distinguish a manageable plan from a low introductory price followed by an unclear sequence of appointments.

Also consider the value of diagnosis. If the actual concern is dermatitis or a pigment condition, buying an injectable package may delay the care you need. A consultation that recommends a simpler approach can be useful even when it does not lead to a procedure. The objective is a suitable plan, not participation in the newest treatment trend.

Check the route of use on every product

A topical cosmetic and an injectable can share branding without sharing the same formulation or intended route. Keep the packaging or product details clear when discussing treatment. Never assume that a serum intended for the skin surface is suitable for injection because it uses familiar PN or PDRN terminology.

Frequently asked questions

Is salmon DNA the same as salmon sperm?

The popular phrase refers to the biological source of processed DNA-derived material, not the injection of raw biological material. It is an imprecise nickname and does not identify a finished product. Ask for the formulation and patient information rather than making a decision based on the phrase alone. [1] [2]

Will PN change my own DNA?

Aesthetic use of these materials should not be described as gene editing or as changing inherited DNA. The name refers to the material category. Claims about repair or regeneration should still be linked to evidence for the actual treatment rather than interpreted as a change to your genetic identity.

Is a serum a safer substitute for an injection?

It is a different route and product category, with different possible benefits and risks. A topical product can still irritate skin or be unsuitable for a particular person. It should not be assumed to give the same result as an injectable, and an injectable should never be applied through an improvised home procedure.

Can I choose a product just by PN percentage?

No. Concentration is only one part of a formulation. Product quality, intended use, evidence, technique and patient selection also matter. A higher percentage does not automatically establish better outcomes or suitability. Compare named products for the same goal rather than treating one number as a performance ranking.

What if I want treatment around the eyes?

The eye area needs its own assessment. Thin skin, pigment, swelling and structural hollows can produce a similar tired appearance but require different decisions. Ask what the proposed product is expected to improve, what will remain and what evidence supports that particular use. [3]

Your decision checklist

Identify whether the product is PN, PDRN or a different formulation.
Distinguish an injectable from a topical product sharing the brand.
Match the evidence to the exact product and intended concern.
Review ingredient-related precautions and avoid promises based only on a mechanism.

Discuss your next step with Reformery

Review Reformery’s skin booster information and ask the team which formulation, evidence and aftercare apply to your proposed treatment.

Medical disclaimer

General information only. Individual assessment and clinician-led aftercare are essential. This article does not replace an examination, diagnosis or personalised medical advice. The featured image is an AI-generated illustration, not a real patient, staff member or treatment result.

Salmon DNA vs Rejuran: Are They the Same? PN and PDRN Explained Simply